Viewing Study NCT06205758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:16 AM
Ignite Modification Date: 2026-02-24 @ 5:07 AM
Study NCT ID: NCT06205758
Status: RECRUITING
Last Update Posted: 2024-01-16
First Post: 2024-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With Acute and Advanced Heart Failure With Renal Insufficiency
Sponsor: Yi Han
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure View
None Levosimendan View
None Milrinone View
None Efficacy View
None Safety View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute and advanced heart failure View
None Milrinone View
None Levosimendan View
None renal insufficiency View